Page last updated: 2024-08-25

tetramethylrhodamine iodoacetamide and Carcinoma

tetramethylrhodamine iodoacetamide has been researched along with Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldwin, RW; Berry, N; Byers, VS; Durrant, L; Garnett, MC; Pawlucyzk, I; Pawluczyk, I; Price, MR; Robins, RA1

Other Studies

1 other study(ies) available for tetramethylrhodamine iodoacetamide and Carcinoma

ArticleYear
Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.
    Journal of immunology (Baltimore, Md. : 1950), 1988, Jun-01, Volume: 140, Issue:11

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Antigen-Antibody Reactions; Binding Sites, Antibody; Carcinoembryonic Antigen; Carcinoma; Cell Line; Cytotoxicity, Immunologic; Endocytosis; Epitopes; Humans; Immunotoxins; Mice; Rhodamines; Ricin; Serum Albumin; Stomach Neoplasms

1988